User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial.

  • Open access
  • PDF
  • 107.35 K
  1. Richards James, Gunson Bridget, Johnson Jill, Neuberger James, Weight gain and obesity after liver transplantation, 10.1111/j.1432-2277.2004.00067.x
  2. Muñoz Santiago J., ElGenaidi Hisham, Cardiovascular risk factors after liver transplantation, 10.1002/lt.20602
  3. la Fleur SE, Diabetes, 52, 2321 (2003)
  4. Guerciolini R, Int J Obes Relat Metab Disord, 21, S12 (1997)
  5. Sjöström Lars, Rissanen Aila, Andersen Teis, Boldrin Mark, Golay Alain, Koppeschaar Hans PF, Krempf Michel, Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients, 10.1016/s0140-6736(97)11509-4
  6. Davidson Michael H., Hauptman Jonathan, DiGirolamo Mario, Foreyt John P., Halsted Charles H., Heber David, Heimburger Douglas C., Lucas Charles P., Robbins David C., Chung Jain, Heymsfield Steven B., Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat : A Randomized Controlled Trial, 10.1001/jama.281.3.235
  7. Zhi J, J Clin Pharmacol, 42, 1011 (2002)
  8. ??sberg Anders, Interactions Between Cyclosporin and Lipid-Lowering Drugs : Implications for Organ Transplant Recipients, 10.2165/00003495-200363040-00003
  9. Cailotto C, Eur J Neurosci, 22, 2531 (2005)
  10. Errasti P, Garcı́a I, Lavilla J, Ballester B, Manrique J, Purroy A, Reduction in blood cyclosporine concentration by Orlistat in two renal transplant patients, 10.1016/s0041-1345(01)02829-9
  11. Nägele H., Petersen B., Bonacker U., Rödiger W., Effect of orlistat on blood cyclosporin concentration in an obese heart transplant patient, 10.1007/s002280050690
  12. Kim DH, Taehan Kan Hakhoe Chi, 8, 317 (2002)
  13. Lau G, Med Sci Law, 42, 309 (2002)
  14. Chounta A, Ann Intern Med, 143, 763 (2005)
Bibliographic reference Cassiman, David ; Roelants, Mieke ; Vandenplas, Gerda ; Van der Merwe, Schalk W ; Mertens, Ann ; et. al. Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial.. In: Transplant International, Vol. 19, no.12, p. 1000-1005 (2006)
Permanent URL http://hdl.handle.net/2078/187316